Source: Medthority

Lilly: Eli Lilly to Acquire Aurka Pharma

Eli Lilly to acquire Aurka Pharma and AK-01, an Aurora kinase A inhibitor in early trials for solid tumors.

Read full article »

Lilly's Competitors | Lilly's News | Lilly's Financials

Followers on Owler

23,667

Annual Revenue

$10-50B

Employees

10-50K

Chairman & CEO

David A. Ricks

CEO Approval Rating

80/100

Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.